BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28160345)

  • 1. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
    Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
    Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.
    Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L
    Addiction; 2014 Aug; 109(8):1306-17. PubMed ID: 24612249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study.
    Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L
    BMJ Open; 2014 Apr; 4(4):e004666. PubMed ID: 24694626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release.
    Bird SM; Fischbacher CM; Graham L; Fraser A
    Addiction; 2015 Oct; 110(10):1617-24. PubMed ID: 25940815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
    Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L
    Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.
    Bazazi AR; Culbert GJ; Wegman MP; Heimer R; Kamarulzaman A; Altice FL
    BMC Infect Dis; 2022 Nov; 22(1):837. PubMed ID: 36368939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study.
    Durand L; O'Driscoll D; Boland F; Keenan E; Ryan BK; Barry J; Bennett K; Fahey T; Cousins G
    Addiction; 2020 Oct; 115(10):1867-1877. PubMed ID: 32034837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
    Lim S; Cherian T; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; MacDonald R; Lee JD
    Addiction; 2023 Mar; 118(3):459-467. PubMed ID: 36305669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007-2013.
    Larney S; Lai W; Dolan K; Zador D
    J Subst Abuse Treat; 2016 Nov; 70():58-63. PubMed ID: 27692189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
    Parmar MK; Strang J; Choo L; Meade AM; Bird SM
    Addiction; 2017 Mar; 112(3):502-515. PubMed ID: 27776382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review.
    Loh DA; Plugge E; Van Hout MC
    Int J Drug Policy; 2023 Feb; 112():103957. PubMed ID: 36693296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.
    Winter RJ; Stoové M; Degenhardt L; Hellard ME; Spelman T; Jenkinson R; McCarthy DR; Kinner SA
    Drug Alcohol Depend; 2015 Aug; 153():43-9. PubMed ID: 26105708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
    Larney S; Toson B; Burns L; Dolan K
    Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.
    Binswanger IA; Blatchford PJ; Mueller SR; Stern MF
    Ann Intern Med; 2013 Nov; 159(9):592-600. PubMed ID: 24189594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study.
    Forsyth SJ; Carroll M; Lennox N; Kinner SA
    Addiction; 2018 May; 113(5):937-945. PubMed ID: 29154395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy.
    Bogdanowicz KM; Stewart R; Chang CK; Shetty H; Khondoker M; Day E; Hayes RD; Strang J
    Addiction; 2018 May; 113(5):946-951. PubMed ID: 29179255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy.
    Jerkeman A; Håkansson A; Rylance R; Wagner P; Alanko Blomé M; Björkman P
    Drug Alcohol Rev; 2017 May; 36(3):424-431. PubMed ID: 27241955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.